Literature DB >> 15617777

Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene.

Philip Barnes1, Mark Good.   

Abstract

The processing of emotional and/or fear-related events is abnormal in patients with Alzheimer's disease. AD is accompanied by a number of neuropathological features, one of which is the deposition of amyloid plaques. The main aim of the present study was to examine the effects of a human amyloid precursor protein mutation on both the acquisition and expression of fear conditioning in Tg2576 mice. Sixteen-month-old, but not 4-month-old, transgenic mice showed aberrations in post-shock freezing during training. In a retention test carried out 24 h after training, Tg2576 mice showed comparable levels of conditioned fear elicited by contextual cues. However, freezing elicited by a tone conditioned stimulus was impaired in 16-month-old but not 4-month-old Tg2576 mice. The results are discussed with reference to the role of cue competition (overshadowing) in revealing fear conditioning deficits in Tg2576 mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617777     DOI: 10.1016/j.bbr.2004.06.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  17 in total

1.  Transcriptional regulation of β-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments.

Authors:  Jin Chu; Jia-Min Zhuo; Domenico Praticò
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

2.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

3.  Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.

Authors:  Jennifer Horgan; Jose Javier Miguel-Hidalgo; Martha Thrasher; Garth Bissette
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

4.  Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.

Authors:  Cynthia A Massaad; Taneasha M Washington; Robia G Pautler; Eric Klann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  Biochemical, molecular and behavioral phenotypes of Rab3A mutations in the mouse.

Authors:  S Yang; M Farias; D Kapfhamer; J Tobias; G Grant; T Abel; M Bućan
Journal:  Genes Brain Behav       Date:  2007-02       Impact factor: 3.449

6.  A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment.

Authors:  Alice L Blackshear; Wenjin Xu; Maria Anderson; Feng Xu; Mary Lou Previti; William E Van Nostrand; John K Robinson
Journal:  Neurobiol Learn Mem       Date:  2011-07-08       Impact factor: 2.877

7.  Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.

Authors:  Kwok Kin Cheng; Chin Fung Yeung; Shuk Wai Ho; Shing Fung Chow; Albert H L Chow; Larry Baum
Journal:  AAPS J       Date:  2012-12-11       Impact factor: 4.009

8.  Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Carla M Yuede; Carolyn Coughlan; Brian Lewis; John G Csernansky
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

9.  Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease.

Authors:  Laura Beth J McIntire; Diego E Berman; Jennifer Myaeng; Agnieszka Staniszewski; Ottavio Arancio; Gilbert Di Paolo; Tae-Wan Kim
Journal:  J Neurosci       Date:  2012-10-31       Impact factor: 6.167

10.  Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Carla M Yuede; Carolyn A Coughlan; Keely M Murphy; John G Csernansky
Journal:  Brain Res       Date:  2009-09-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.